Skip to main content

Navigation group

Main content

Overview

Transplant International is the official journal of the European Society for Organ Transplantation (ESOT)Transplant International aims to be the premier journal publishing the key basic science and clinical developments in organ replacement medicine, including all aspects of transplantation, organ reconditioning, cell therapy, regenerative medicine, bioengineering and artificial organs.

Please note: Because they concern the unrelated field of onco-hematology, Transplant International does not accept submissions in the field of hematopoietic stem cell transplantation (HSCT).

Aims and scope

The aim of the journal is to serve as a forum for the exchange of scientific information in the form of original and high quality papers in the field of transplantation. Clinical and experimental studies, as well as editorials, letters to the editors, and, occasionally, reviews on the biology, physiology, and immunology of transplantation of tissues and organs, are published. Publishing time for the latter is approximately six months, provided major revisions are not needed. Papers submitted to the journal are subject to a thorough double-blind peer review model.

Journal Information

  • Short name

    Transpl Int

  • Abbreviation

    ti

  • Electronic ISSN

    1432-2277

  • PMCID

    All published articles receive a PMCID

  • Impact

    3.1 Impact Factor

    4.7 CiteScore

  • Indexed in

    1Science, Bielefeld Academic Search Engine (BASE), Chemical Abstracts Service (CAS), Chinese Academy of Sciences GoOA, CLOCKSS, CNKI Scholar, CrossRef, Dimensions, DOAJ, EBSCO, Embase, Figshare, Google Scholar, Jisc, MEDLINE, MyScienceWork, OpenAIRE, ProQuest Biological Science Database, ProQuest Central, ProQuest Health & Medical Collection, ProQuest Health Research Premium Collection, ProQuest Medical Database, ProQuest SciTech Premium Collection, PubMed Central (PMC), SCImago (SJR), Scite, Scopus, Semantic Scholar, Sherpa/Romeo, Web of Science Science Citation Index Expanded (SCIE)

DEI Statement

At Transplant International, we believe that diversity is the essence of humankind. We value engagement and inclusion at all stages of science communication and dissemination, from the submission of research manuscripts, through the editorial and review process and on to publication. We welcome submissions from applicants of all ethnicities, nationalities, religions, gender identities, sexual orientations or other individual status, and are committed to eliminating the influence of any bias in our processes.

We recognise that this endeavour requires an ongoing commitment; the journal will continually review its practices in this regard and welcomes any feedback from our authors and community.

Open access statement

Open access logo

Transplant International provides online free gold open access to the journal and all of its research publications.

Open Access funder and institutional mandates: Transplant International is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution licence (CC-BY). Funder mandates such as those by the Wellcome Trust (UK), National Institutes of Health (USA) and the Australian Research Council (Australia) are fully compatible with publishing in Transplant International. Authors retain copyright of their work and can deposit their publication in any repository. The work can be freely shared and adapted provided that appropriate credit is given and any changes specified.

Quality

Each Transplant International article strives for the highest quality, thanks to genuinely collaborative interactions between authors, editors and reviewers. Transplant International encourages authors to consult the instructions for authors guidelines prior to submission.